82_FR_11961 82 FR 11924 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

82 FR 11924 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 37 (February 27, 2017)

Page Range11924-11925
FR Document2017-03704

Federal Register, Volume 82 Issue 37 (Monday, February 27, 2017) 
[Federal Register Volume 82, Number 37 (Monday, February 27, 2017)]
[Notices]
[Pages 11924-11925]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-03704]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 11925]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI Clinical Trial Pilot Studies (R34).
    Date: March 17, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 
20892-7924, 301-827-7942, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Collaborative Projects in Organ Fibrosis.
    Date: March 21, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Kristen Page, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7185, Bethesda, MD 20892, 301-827-7953, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: February 21, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-03704 Filed 2-24-17; 8:45 am]
 BILLING CODE 4140-01-P

11924 Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices copies total. One copy will include the models that may predict response in our best to accommodate requests to information you claim to be confidential humans could advance the development make public comments. Individuals and with a heading or cover note that states of antibacterial drugs targeting a single organizations with common interests are ‘‘THIS DOCUMENT CONTAINS species. urged to consolidate or coordinate their CONFIDENTIAL INFORMATION.’’ The FDA is particularly interested in presentations, and request time for a Agency will review this copy, including infections due to Acinetobacter joint presentation. All requests to make the claimed confidential information, in baumannii and Pseudomonas oral presentations must be received by its consideration of comments. The aeruginosa as pathogens because there February 27, 2017. We will determine second copy, which will have the are limited therapeutic options to treat the amount of time allotted to each claimed confidential information patients with serious infections caused presenter and the approximate time redacted/blacked out, will be available by these bacteria, including those each oral presentation is to begin, and for public viewing and posted on resistant to currently available will select and notify participants on or https://www.regulations.gov. Submit antibacterial drugs. In addition, it is before February 28, 2017. If selected for both copies to the Division of Dockets difficult to enroll an adequate number of presentation, any presentation materials Management. If you do not wish your patients to conduct clinical trials since must be emailed to AnimalModels name and contact information to be the frequency with which these InfectionWorkshop2017@fda.hhs.gov no made publicly available, you can organisms cause clinical disease is later than February 28, 2017. No provide this information on the cover sufficiently low. Discussions will focus commercial or promotional material sheet and not in the body of your on the current state of animal models of will be permitted to be presented or comments and you must identify this serious infections, lessons learned from distributed at the public workshop. information as ‘‘confidential.’’ Any the development efforts for past and Transcripts: Please be advised that as information marked as ‘‘confidential’’ current animal models of infection, and soon as a transcript is available, it will will not be disclosed except in scientific challenges and future be accessible at https:// accordance with 21 CFR 10.20 and other direction and next steps in animal www.regulations.gov. It may be viewed applicable disclosure law. For more model development. at the Division of Dockets Management information about FDA’s posting of This public workshop is intended to provide information for and gain (HFA–305), Food and Drug comments to public dockets, see 80 FR Administration, 5630 Fishers Lane, Rm. 56469, September 18, 2015, or access perspective from health care providers, other U.S. Government Agencies, 1061, Rockville, MD 20852. A transcript the information at: http://www.fda.gov/ will also be available in either hardcopy regulatoryinformation/dockets/ academic experts, contract research organizations, and industry on various or on CD–ROM, after submission of a default.htm. Freedom of Information request. The Docket: For access to the docket to aspects of development efforts pertaining to animal models of serious Freedom of Information office address is read the electronic and written/paper available on the Agency’s Web site at comments received, go to https:// infections. The input from this public workshop will also help FDA in http://www.fda.gov. Transcripts will www.regulations.gov and insert the also be available on the Internet at: docket number, found in brackets in the developing topics for future discussion. The Agency encourages health care http://www.fda.gov/Drugs/NewsEvents/ heading of this document, into the ucm534031.htm approximately 45 days ‘‘Search’’ box and follow the prompts providers, other U.S. Government Agencies, academic experts, contract after the workshop. and/or go to the Division of Dockets research organizations, industry, and Dated: February 21, 2017. Management, 5630 Fishers Lane, Rm. other interested persons to attend this Leslie Kux, 1061, Rockville, MD 20852. public workshop. Associate Commissioner for Policy. FOR FURTHER INFORMATION CONTACT: Lori Registration: Interested parties are Benner and/or Jessica Barnes, Center for [FR Doc. 2017–03751 Filed 2–24–17; 8:45 am] encouraged to register early. To register Drug Evaluation and Research, Food electronically, email registration BILLING CODE 4164–01–P and Drug Administration, 10903 New information (including name, title, firm Hampshire Ave., Bldg. 22, Rm. 6221, name, address, telephone, and fax Silver Spring, MD 20993–0002, 301– DEPARTMENT OF HEALTH AND number) to AnimalModelsInfection HUMAN SERVICES 796–1300. Workshop2017@fda.hhs.gov. Persons SUPPLEMENTARY INFORMATION: FDA is without access to the Internet can call National Institutes of Health announcing a public workshop 301–796–1300 to register. Registration is regarding animal model development free and will be on a first-come, first- National Heart, Lung, and Blood for infectious diseases. FDA is served basis. However, FDA may limit Institute; Notice of Closed Meetings conducting this workshop in order to the number of participants from each facilitate the development of narrow- organization based on space limitations. Pursuant to section 10(d) of the spectrum antibacterial drugs, such as Registrants will receive confirmation Federal Advisory Committee Act, as those that are active against only a once they have been accepted. Onsite amended (5 U.S.C. App.), notice is single species of bacteria that may not registration on the day of the meeting hereby given of the following meetings. occur frequently. When the species will be based on space availability. The meetings will be closed to the occurs infrequently, performing clinical If you need special accommodations public in accordance with the trials can be extremely challenging. due to a disability, please contact Jessica provisions set forth in sections Therefore, animal models of infection Barnes or Lori Benner (see FOR FURTHER 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., mstockstill on DSK3G9T082PROD with NOTICES may be useful to explore the activity of INFORMATION CONTACT) at least 7 days in as amended. The grant applications and a candidate antibacterial drug and may advance. the discussions could disclose help to predict whether the drug will be Requests for Oral Presentations: confidential trade secrets or commercial efficacious in humans. A discussion of During online registration you may property such as patentable material, the additional scientific work needed to indicate if you wish to present during a and personal information concerning evaluate current animal models of public comment session, and which individuals associated with the grant infection and evaluate potential animal topic(s) you wish to address. We will do applications, the disclosure of which VerDate Sep<11>2014 20:23 Feb 24, 2017 Jkt 241001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1

Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices 11925 would constitute a clearly unwarranted The meeting will be closed to the DEPARTMENT OF HEALTH AND invasion of personal privacy. public as indicated below in accordance HUMAN SERVICES Name of Committee: National Heart, Lung, with the provisions set forth in section and Blood Institute Special Emphasis Panel; 552b(c)(6), Title 5 U.S.C., as amended National Institutes of Health NHLBI Clinical Trial Pilot Studies (R34). for review, discussion, and evaluation of Date: March 17, 2017. individual intramural programs and National Institute of General Medical Time: 8:30 a.m. to 5:00 p.m. projects conducted by the NATIONAL Sciences; Notice of Closed Meeting Agenda: To review and evaluate grant LIBRARY OF MEDICINE, including Pursuant to section 10(d) of the applications. consideration of personnel Place: Hyatt Regency Bethesda, One Federal Advisory Committee Act, as Bethesda Metro Center, 7400 Wisconsin qualifications and performance, and the amended (5 U.S.C. App.), notice is Avenue, Bethesda, MD 20814. competence of individual investigators, hereby given of the following meeting. Contact Person: YingYing Li-Smerin, MD, the disclosure of which would The meeting will be closed to the Ph.D., Scientific Review Officer, Office of constitute a clearly unwarranted public in accordance with the Scientific Review/DERA, National Heart, invasion of personal privacy. provisions set forth in sections Lung, and Blood Institute, 6701 Rockledge 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Drive, Room 7184, Bethesda, MD 20892– Name of Committee: Board of Scientific Counselors, National Center for as amended. The grant applications and 7924, 301–827–7942, lismerin@nhlbi.nih.gov. the discussions could disclose Name of Committee: National Heart, Lung, Biotechnology Information. Date: May 2, 2017. confidential trade secrets or commercial and Blood Institute Special Emphasis Panel; property such as patentable material, Collaborative Projects in Organ Fibrosis. Open: 8:30 a.m. to 12:00 p.m. Agenda: Program Discussion. and personal information concerning Date: March 21, 2017. Time: 8:30 a.m. to 5:00 p.m. Place: National Library of Medicine, individuals associated with the grant Agenda: To review and evaluate grant Building 38, 2nd Floor, The Lindberg Room, applications, the disclosure of which applications. 8600 Rockville Pike, Bethesda, MD 20892. would constitute a clearly unwarranted Place: Courtyard by Marriott, 5520 Closed: 12:00 p.m. to 2:00 p.m. invasion of personal privacy. Wisconsin Avenue, Chevy Chase, MD 20815. Agenda: To review and evaluate personal Name of Committee: National Institute of Contact Person: Kristen Page, Ph.D., qualifications and performance, and General Medical Sciences Special Emphasis Scientific Review Officer, Office of Scientific Panel Review of U54 Application. competence of individual investigators. Review/DERA, National Heart, Lung, and Date: March 30, 2017. Place: National Library of Medicine, Blood Institute, National Institutes of Health, Time: 8:30 a.m. to 5:00 p.m. 6701 Rockledge Drive, Room 7185, Bethesda, Building 38, 2nd Floor, The Lindberg Room, Agenda: To review and evaluate grant MD 20892, 301–827–7953, kristen.page@ 8600 Rockville Pike, Bethesda, MD 20892. applications. nih.gov. Open: 2:00 p.m. to 3:00 p.m. Place: Hilton Garden Inn Bethesda, 7301 (Catalogue of Federal Domestic Assistance Agenda: Program Discussion. Waverly Street, Bethesda, MD 20814. Program Nos. 93.233, National Center for Place: National Library of Medicine, Contact Person: Lisa A. Dunbar, Scientific Sleep Disorders Research; 93.837, Heart and Building 38, 2nd Floor, The Lindberg Room, Review Officer, Office of Scientific Review, Vascular Diseases Research; 93.838, Lung 8600 Rockville Pike, Bethesda, MD 20892. National Institute of General Medical Diseases Research; 93.839, Blood Diseases Contact Person: David J. Lipman, MD, Sciences, National Institutes of Health, 45 and Resources Research, National Institutes Director, National Center for Biotechnology Center Drive, Room 3AN12, Bethesda, MD of Health, HHS) Information, National Library of Medicine, 20892, 301–594–2849, dunbarl@mail.nih.gov. Building 38A, Room 8N805, Bethesda, MD (Catalogue of Federal Domestic Assistance Dated: February 21, 2017. 20892, 301–435–5985, dlipman@ Program Nos. 93.375, Minority Biomedical Michelle Trout, Research Support; 93.821, Cell Biology and mail.nih.gov. Program Analyst, Office of Federal Advisory Biophysics Research; 93.859, Pharmacology, Any interested person may file written Committee Policy. Physiology, and Biological Chemistry comments with the committee by forwarding Research; 93.862, Genetics and [FR Doc. 2017–03704 Filed 2–24–17; 8:45 am] the statement to the Contact Person listed on Developmental Biology Research; 93.88, BILLING CODE 4140–01–P this notice. The statement should include the Minority Access to Research Careers; 93.96, name, address, telephone number and when Special Minority Initiatives; 93.859, applicable, the business or professional Biomedical Research and Research Training, DEPARTMENT OF HEALTH AND affiliation of the interested person. National Institutes of Health, HHS) HUMAN SERVICES In the interest of security, NIH has instituted stringent procedures for entrance Dated: February 22, 2017. National Institutes of Health Melanie J. Pantoja, onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles Program Analyst, Office of Federal Advisory National Library of Medicine; Notice of Committee Policy. Meeting will be inspected before being allowed on campus. Visitors will be asked to show one [FR Doc. 2017–03822 Filed 2–24–17; 8:45 am] Pursuant to section 10(a) of the form of identification (for example, a BILLING CODE 4140–01–P Federal Advisory Committee Act, as government-issued photo ID, driver’s license, amended (5 U.S.C. App), notice is or passport) and to state the purpose of their hereby given of a meeting of the Board visit. DEPARTMENT OF HEALTH AND of Scientific Counselors, National (Catalogue of Federal Domestic Assistance HUMAN SERVICES Center for Biotechnology Information. Program No. 93.879, Medical Library The meeting will be open to the Assistance, National Institutes of Health, National Institutes of Health public as indicated below, with mstockstill on DSK3G9T082PROD with NOTICES HHS) National Heart, Lung, and Blood attendance limited to space available. Dated: February 21, 2017. Institute; Notice of Meeting Individuals who plan to attend and need special assistance, such as sign Michelle Trout, Pursuant to section 10(a) of the language interpretation or other Program Analyst, Office of Federal Advisory Federal Advisory Committee Act, as reasonable accommodations, should Committee Policy. amended (5 U.S.C. App.), notice is notify the Contact Person listed below [FR Doc. 2017–03702 Filed 2–24–17; 8:45 am] hereby given of a meeting of the Sickle in advance of the meeting. BILLING CODE 4140–01–P Cell Disease Advisory Committee. VerDate Sep<11>2014 20:23 Feb 24, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1


Document Created: 2017-02-25 01:05:45
Document Modified: 2017-02-25 01:05:45
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 17, 2017.
FR Citation82 FR 11924 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR